271 related articles for article (PubMed ID: 11849126)
1. Review article: the effect of Helicobacter pylori infection on nonsteroidal anti-inflammatory drug-induced upper gastrointestinal tract injury.
Laine L
Aliment Pharmacol Ther; 2002 Mar; 16 Suppl 1():34-9. PubMed ID: 11849126
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.
Aalykke C; Lauritsen JM; Hallas J; Reinholdt S; Krogfelt K; Lauritsen K
Gastroenterology; 1999 Jun; 116(6):1305-9. PubMed ID: 10348813
[TBL] [Abstract][Full Text] [Related]
3. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori, NSAIDs and gastrointestinal haemorrhage.
Chan FK
Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):1-3. PubMed ID: 11782567
[TBL] [Abstract][Full Text] [Related]
5. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
7. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori infection and the use of NSAIDs.
Bazzoli F; De Luca L; Graham DY
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
[TBL] [Abstract][Full Text] [Related]
9. Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study.
Okan A; Tankurt E; Aslan BU; Akpinar H; Simsek I; Gonen O
J Gastroenterol Hepatol; 2003 Jan; 18(1):18-25. PubMed ID: 12519219
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori infection and gastroduodenal injury by non-steroidal anti-inflammatory drugs.
McCarthy DM
Scand J Gastroenterol Suppl; 1991; 187():91-7. PubMed ID: 1775931
[TBL] [Abstract][Full Text] [Related]
11. H. pylori and risk of ulcer bleeding among users of NSAIDS.
Atherton JC; Wight NJ
Gastroenterology; 2000 Feb; 118(2):451-2. PubMed ID: 10691374
[No Abstract] [Full Text] [Related]
12. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
13. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
;
Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
[TBL] [Abstract][Full Text] [Related]
14. [Significance of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in patients with bleeding from upper part of the gastrointestinal tract].
Golubović G; Tomasević R; Radojević B; Pavlović A; Dugalić P
Vojnosanit Pregl; 2007 Jul; 64(7):445-8. PubMed ID: 17821917
[TBL] [Abstract][Full Text] [Related]
15. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan.
Ootani H; Iwakiri R; Shimoda R; Nakahara S; Amemori S; Fujise T; Kikkawa A; Tsunada S; Sakata H; Fujimoto K
J Gastroenterol; 2006 Jan; 41(1):41-6. PubMed ID: 16501856
[TBL] [Abstract][Full Text] [Related]
16. Review article: should NSAID/low-dose aspirin takers be tested routinely for H. pylori infection and treated if positive? Implications for primary risk of ulcer and ulcer relapse after initial healing.
Hunt RH; Bazzoli F
Aliment Pharmacol Ther; 2004 Feb; 19 Suppl 1():9-16. PubMed ID: 14725573
[TBL] [Abstract][Full Text] [Related]
17. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
Bianchi Porro G; Parente F; Imbesi V; Montrone F; Caruso I
Gut; 1996 Jul; 39(1):22-6. PubMed ID: 8881802
[TBL] [Abstract][Full Text] [Related]
18. [Impact of Helicobacter pylori infection on the risk of gastro-duodenal ulcer in patients treated with nonsteroidal antiinflammatory drugs].
Thiéfin G; Jolly D
Gastroenterol Clin Biol; 2004 Apr; 28 Spec No 3():C45-57. PubMed ID: 15366674
[TBL] [Abstract][Full Text] [Related]
19. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
20. The relation between Helicobacter pylori and nonsteroidal anti-inflammatory drugs.
Barkin J
Am J Med; 1998 Nov; 105(5A):22S-27S. PubMed ID: 9855172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
